Go to Page # Page of 74

Future of Cancer Care Through Biologic Profiling & Big Data

 Thomas Brown MD
Description: This paper describes the anti-tumor activity and toxicity of commercially available, targeted anticancer drugs prescribed for the treatment of patients with advanced solid tumors.
Views: 682
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Swedish Cancer Institute
 ‐ More of their Presentations
The Future of Cancer Care Through
Biologic Profiling and Big Data
How the Experts Treat Hematologic Malignancies
City of Hope Symposium
Las Vegas, Nevada
March 21st, 2019

Thomas Brown, MD, MBA
Executive Director, Swedish Cancer Institute
Seattle, Washington

GenomiCare, Inc. – Member, Scientific Advisory Board
Jiahui Holding Co., Ltd – Lead Clinical Advisor
Spe ... See more

Recent Presentations

What's Trust Have To Do With Compassion?

Trends of trust in healthcare. Trust needed for conversation between patients & physicians on overuse. Trust should be a core operating principle in health care.

21 August, 2019
20 August, 2019
Yalin Firinci
19 August, 2019